{
  "abstract": "Seeding trials—clinical studies designed primarily for marketing rather than scientific advancement—pose underappreciated risks to research integrity and patient safety. Sukhun Kang and colleagues argue for stronger transparency measures and coordinated global oversight to address this hidden practice.",
  "authors": [
    {
      "affiliations": [
        "Technology Management, UC Santa Barbara, Santa Barbara, California, USA"
      ],
      "name": "Sukhun Kang"
    },
    {
      "affiliations": [
        "Technology Management, UC Santa Barbara, Santa Barbara, California, USA"
      ],
      "name": "Ivan Lin"
    },
    {
      "affiliations": [
        "Johnson Graduate School of Management, Cornell University, Ithaca, New York, USA"
      ],
      "name": "Sungyong Chang"
    }
  ],
  "title": "Uncovering seeding trials: examining non-scientific purposes in clinical trials",
  "uid": "21b28aa4-7707-5cb5-89ce-bd7fe8974485"
}